ANTHERA PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAnthera Pharmaceuticals Inc • November 8th, 2012 • Pharmaceutical preparations • New York
Company FiledNovember 8th, 2012 Industry JurisdictionAnthera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows: